Serzone withdrawal sought by Public Citizen
Public Citizen sues FDA to force the withdrawal of Bristol-Myers Squibb's antidepressant Serzone (nefazodone). The 1suit, filed in D.C. federal court March 15, cites a "mounting number of deaths and serious injuries from liver failure." The lawsuit follows a March 5, 2003 citizen petition from Public Citizen - supplemented in October - asking FDA to withdraw the product (2"The Pink Sheet" March 10, 2003, p. 17)...
You may also be interested in...
Bristol-Myers Squibb's Serzone offers "no unique therapeutic benefit" to justify continued marketing in light of liver toxicity concerns, Public Citizen maintains in a March 6 petition to FDA
STADA Strengthens Specialty Partnership Role Via US Filing
Textualist judges appointed by President Trump during his term may block a potential President Biden’s attempts to shift the government’s legal policies, experts tell Medtech Insight.